Highlights and Quick Summary
- EBT margin for the quarter ending December 31, 2022 was 108.37% (a -335.54% decrease compared to previous quarter)
- Year-over-year quarterly EBT margin decreased by -279.72%
- Annual EBT margin for 2022 was -297.17% (a -61.79% decrease from previous year)
- Annual EBT margin for 2021 was -777.79% (a 138.06% increase from previous year)
- Annual EBT margin for 2020 was -326.72% (a 73.07% increase from previous year)
- Twelve month EBT margin ending December 31, 2022 was -297.17% (a 20.01% increase compared to previous quarter)
- Twelve month trailing EBT margin decreased by -40.29% year-over-year
Trailing EBT margin for the last four month:
| 31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
|---|---|---|---|
| -297.17% | -247.63% | -495.99% | -497.68% |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT margin of Precigen, Inc.
Most recent EBT marginof PGEN including historical data for past 10 years.Interactive Chart of EBT margin of Precigen, Inc.
Precigen, Inc. EBT margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | 108.37% | -46.01% | -898.25% | -60.3% | -297.17% |
| 2021 | 182.22% | -791.48% | -812.56% | -89.33% | -777.79% |
| 2020 | 77.73% | -116.97% | -52.03% | -69.73% | -326.72% |
| 2019 | -217.5% | -268.09% | -98.41% | -234.28% | -188.78% |
| 2018 | -601.95% | -225.18% | -150.1% | -129.82% | -261.88% |
| 2017 | 25.54% | -90.52% | -37.62% | -61.23% | -35.71% |
| 2016 | -98.91% | -62.12% | -96.42% | -155.63% | -101.69% |
| 2015 | -79.68% | -74.86% | -90.35% | 78.58% | -50.1% |
| 2014 | 57.27% | -254.1% | -451.5% | 45.26% | -119.17% |
| 2013 | -182.25% | 248.11% | -97.44% | -935.96% | -172.17% |
| 2012 | -700.51% | -606.57% | – | – | -594.41% |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology